Facilitating Positive Adaptation to Breast Cancer

Sponsor
University of Miami (Other)
Overall Status
Completed
CT.gov ID
NCT01422551
Collaborator
National Cancer Institute (NCI) (NIH)
240
1
2
95
2.5

Study Details

Study Description

Brief Summary

The purpose of this study is to test the effects of a 10-wk cognitive behavioral stress management (CBSM) intervention vs. a single-day psycho-educational seminar on psychosocial adaptation and physiological adaptation in women being treated for stage I-III breast cancer.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Cognitive Behavioral Stress Management
  • Behavioral: a psycho-educational control
Phase 2

Detailed Description

The study tests the effects of a 10-wk group-based cognitive behavioral stress management (CBSM) intervention (relaxation, stress awareness, cognitive restructuring, coping skills training, interpersonal skills training) versus a single-day psycho-educational seminar (general information about stress and coping) in women who have recently had surgery for breast cancer but have not yet started adjuvant therapy. The study evaluates the effects of CBSM on psychosocial adaptation (includes measures of negative adaptation [distress and social disruption] and positive adaptation [benefit finding and positive affect]) at 6-month and 12-month follow-up. The study also evaluates the effects of CBSM on physiological adaptation (includes levels of PM serum cortisol and T-helper-type 1 (Th1) cytokine [interleukin-2, IL-2, and interferon-gamma, IFN-g, production after anti-CD3 stimulation of peripheral blood mononuclear cells (PBMC).

Study Design

Study Type:
Interventional
Actual Enrollment :
240 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Official Title:
Facilitating Positive Adaptation to Breast Cancer
Study Start Date :
Sep 1, 1999
Actual Primary Completion Date :
Aug 1, 2007
Actual Study Completion Date :
Aug 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cognitive Behavioral Stress Management

10 weekly 2-hour sessions of group-based cognitive behavioral stress management

Behavioral: Cognitive Behavioral Stress Management
10 weekly 2-hour sessions of group-based cognitive behavioral stress management

Active Comparator: Psycho-educational Control

a single day group-based psycho-educational seminar

Behavioral: a psycho-educational control
a single-day psycho-educational seminar

Outcome Measures

Primary Outcome Measures

  1. change from baseline to 12 month follow-up in psychosocial adaptation (less negative affect and social disruption; more benefit finding and positive affect) [baseline and 6 and 12 month follow-up]

    changes in a composite composed of negative affect measures plus a measure of social disruption plus a measure of benefit finding plus a measure of positive affect

Secondary Outcome Measures

  1. change from baseline to 12 months in physiological adaptation (decreased serum cortisol and increased Th1 cytokine production) [baseline and 6 and 12 months follow-up]

    decreased PM levels of serum cortisol and increased Th1 (interleukin-2, interferon-gamma) cytokine production following anti-CD3 stimulation of peripheral blood mononuclear cells (PBMCs)

Eligibility Criteria

Criteria

Ages Eligible for Study:
21 Years to 75 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:

-women diagnosed with breast cancer at stage III or below who had recently undergone lumpectomy or mastectomy

Exclusion Criteria:
  • prior cancer,

  • prior psychiatric treatment for a serious disorder (e.g., psychosis, suicidality),

  • lack of fluency in English and had begun adjuvant therapy at time of first assessment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Department of Psychology University of Miami Coral Gables Florida United States 33124

Sponsors and Collaborators

  • University of Miami
  • National Cancer Institute (NCI)

Investigators

  • Principal Investigator: Michael Antoni, Ph.D., University of Miami

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Michael H. Antoni, Principle Investigator, University of Miami
ClinicalTrials.gov Identifier:
NCT01422551
Other Study ID Numbers:
  • 19930536
  • R01CA064710
First Posted:
Aug 24, 2011
Last Update Posted:
Aug 24, 2011
Last Verified:
Aug 1, 2011
Keywords provided by Michael H. Antoni, Principle Investigator, University of Miami
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 24, 2011